January 10, 2022
THIS PARTNERSHIP INTEGRATES G4’S ACCURACY, SPEED, FLEXIBILITY AND POWER WITH THE TWIST TARGET ENRICHMENT SOLUTIONS TO EMPOWER FIXED AND CUSTOM TARGETED SEQUENCING PANELS FOR CUSTOMERS. LA JOLLA, Calif. -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced a partnership with [...]
January 10, 2022
THIS PARTNERSHIP INTEGRATES G4’S ACCURACY, SPEED, FLEXIBILITY AND POWER WITH THE WATCHMAKER DNA LIBRARY PREP KITS TO EMPOWER INNOVATIVE WORKFLOWS FOR CUSTOMERS LA JOLLA, Calif. -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced a partnership with Watchmaker Genomics to [...]
January 10, 2022
THIS PARTNERSHIP INTEGRATES G4’S ACCURACY, SPEED, FLEXIBILITY AND POWER WITH DOVETAIL’S EXPERTISE IN 3-D GENOME ARCHITECTURE TO EMPOWER SPECIALIZED WORKFLOWS FOR CUSTOMERS. LA JOLLA, Calif. -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced a partnership with Dovetail Genomics to [...]
January 10, 2022
EMERYVILLE, Calif. -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, and Aanika Biosciences, a growing biotech start-up using edible microbial tags to improve food safety, today announced a strategic partnership that will enable faster identification of outbreak sources, reduce incidents of fresh produce contamination and minimize the impact of food borne [...]
January 10, 2022
Acquisition extends CliniSys capabilities into new and complementary market sectors serving environmental, water quality testing, public health, toxicology, and agriculture The acquisition extends CliniSys’ laboratory testing, diagnostics, and management capabilities further into the public health sector and related markets, such as environmental, water quality testing, public health, toxicology, and agricultural testing. Additionally, the acquisition of [...]
Latest tools for COVID-19 Omicron variant research
January 10, 2022
AMSBIO has announced new additions to its portfolio of tools for COVID-19 research - two monoclonal antibodies that recognize the Spike RBD (B.1.1.529, Omicron Variant) protein and neutralizes its interaction with ACE2. The human ACE2 receptor is found on the surface of type I and II pneumocytes, endothelial cells, and ciliated bronchial epithelial cells. Research has shown that ACE2 mediates COVID-19 infection [...]
January 10, 2022
Company has already booked multiple orders and established COEs in three major geographies REDWOOD CITY, Calif. -- Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced Broad Commercial Release of its Proteograph Product Suite and the launch of its Centers of Excellence program. The Proteograph Product Suite [...]
Agilent Presents Thought Leader Award to Professor Jason Kovacic
January 10, 2022
Victor Chang Cardiac Research Institute (VCCRI) researcher recognized for his influential work on cardiovascular disease SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A) today announced that Professor Jason Kovacic has been selected to receive a prestigious Agilent Thought Leader Award. Professor Kovacic is being recognized for his influential research on cardiovascular disease—specifically the pathobiology of vascular diseases, [...]
January 10, 2022
-- Reveals Plug and Play, Low Cost, No Scar, Scalable Enzymatic Synthesis 3.0 -- -- Partners with PacBio, Singular Genomics Enabling New Sequencing Platforms -- SOUTH SAN FRANCISCO, Calif. -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it [...]
January 10, 2022
Delivery of 100,000 samples of capacity annually to the market, empowering genomics researchers to add deep, unbiased proteomics analysis to their studies REDWOOD CITY, Calif. and HUNTSVILLE, Ala. and FRAMINGHAM, Mass. -- Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics; SCIEX, a global leader in life science analytical [...]

